Evaluation of Blood Pressure Measurement in Patients Applying to Outpatient Clinics: A Cross-sectional Study

Year 2023, Volume: 2 Issue: 3, 6 - 10, 30.09.2023

Ömer Faruk Özceylan , Turan Set

https://doi.org/10.59518/farabimedj.1295066

Abstract

The aim of our study was to evaluate the status of blood pressure (BP) measurements in patients applied to outpatient clinics. The study was cross-sectional and was performed at Karadeniz Technical University Faculty of Medicine, Farabi Hospital, Department of Family Medicine. Volunteer patients aged over 18 were included in the study who applied to the family medicine outpatient clinic. A questionnaire form questioning sociodemographic characteristics and whether BP was measured in previous outpatient applications was prepared by the researchers and applied to a total of 172 participants with a face-to-face interview. BPs of the participants were measured and noted during routine physical examination. The average age of participants was 37.8±11.4 years. The median systolic BP was 110 (IQR: 100-120) mmHg, and the median diastolic BP was 70 (IQR: 70-80) mmHg. The two departments with the highest rates of BP measurement in the most recent outpatient clinic that the participants applied were cardiology 71.4% (n=5) and family medicine 71% (n=22). 70.3% (n=121) of the participants BP was not measured in the last outpatient applied. BP was higher than 120/80 mmHg in 37.8% (n=65) of the participants. BP was measured at the last outpatient clinic application in 14.3% (n=1) of patients with stage 2 BP level and 33.3% (n=6) of patients with stage 1 BP level. It was observed that BP was not measured in 70% of the patients during outpatient clinic examinations. At the same time, in our study, it was found that 70% of the patients whose BP was measured at stage 1 and stage 2 hypertension were not measured at the last outpatient clinic application. In addition to BP measurement being a physical examination that should not be skipped in routine evaluation, every application should be considered as an opportunity for BP measurement.

Keywords

Blood pressure measurement, Hypertension, Physical examination

Polikliniklere Başvuran Hastaların Kan Basıncının Ölçülme Durumlarının Değerlendirilmesi: Bir Kesitsel Çalışma

Abstract

Bu çalışmada, polikliniklere başvuran hastaların kan basıncı (KB) ölçümlerinin yapılma durumlarının değerlendirilmesi amaçlanmıştır. Araştırmamız kesitsel nitelikte olup Karadeniz Teknik Üniversitesi Tıp Fakültesi Farabi Hastanesi Aile Hekimliği Anabilim Dalında yapılmıştır. Araştırmaya aile hekimliği polikliniğine başvuran 18 yaşından büyük gönüllü hastalar dahil edilmiştir. Toplam 172 katılımcıya araştırmacılar tarafından sosyodemografik özellikler ve daha önceki poliklinik başvurularında KB ölçümü yapılıp yapılmadığını sorgulayan bir anket formu hazırlanarak yüz yüze görüşme yöntemi ile uygulanmıştır. Katılımcıların rutin fizik muayene sırasında KB’leri ölçülüp not edilmiştir. Katılımcıların yaş ortalaması 37.8±11.4 yıldı. Katılımcıların ortanca sistolik KB değeri 110 (IQR: 100-120) mmHg, ortanca diyastolik KB değeri 70 (IQR: 70-80) mmHg idi. Katılımcıların en son başvurduğu poliklinikte KB ölçülme oranları en yüksek olan iki bölüm kardiyoloji %71.4 (n=5) ve aile hekimliği %71 (n=22) idi. Katılımcıların %70.3 (n=121)’ünün en son poliklinik muayenesinde KB ölçülmemişti. Katılımcıların %37.8 (n=65)’inin KB 120/80 mmHg’dan yüksekti. Ölçülen KB değeri evre 2 sınıfında olan hastaların %14.3 (n=1)’ünün, evre 1 sınıfında olan hastaların %33.3 (n=6)’ünün KB ölçümü son gittiği poliklinik muayenesinde ölçülmüştü. Poliklinik muayenelerinde hastaların %70’inin KB ölçümünün yapılmadığı görülmüştür. Aynı zamanda çalışmamızda KB, evre 1 ve evre 2 hipertansiyon değerinde ölçülen hastaların %70’inin son poliklinik başvurusunda KB’nın ölçülmediği saptanmıştır. KB ölçümünün rutin değerlendirmede atlanmaması gereken bir fizik muayene olması yanında, her başvuru KB ölçümü için bir fırsat olarak değerlendirilmelidir.

Keywords

Kan basıncı ölçümü, Hipertansiyon, Fizik muayene

References

• Aydogdu S, Güler K, Bayram F, et al. 2019 Turkish hypertension consensus report. Turk Kardiyoloji Dernegi Arsivi. 2019; 47(6): 535-546. DOI: 10.5543/tkda.2019.62565.
• Johnson KC, Whelton PK, Cushman WC, et al. Blood pressure measurement in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 2018; 71(5): 848-857. DOI: 10.1161/hypertensionaha.117.10479.
• World Health Organization. A global brief on hypertension: Silent Killer, Global Public Health Crisis. https://www.who.int/publications/i/item/a-global-brief-on-hypertension-silent-killer-global-public-health-crisis-world-health-day-2013. Publication date: June 2013.
• World Health Organization. Global status report on noncommunicable diseases 2014. https://www.who.int/publications/i/item/978924156485. Publication date: October 2014.
• Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013; 310(9): 959-968. DOI:10.1001/jama.2013.184182.
• Sengul S, Akpolat T, Erdem Y, et al. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens. 2016; 34(6): 1208-1217. DOI:10.1097/HJH.0000000000000901.
• Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013; 28(2): 169-180. DOI:10.1007/s10654-013-9771-5.
• GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159): 1923-1994. DOI: 10.1016/S0140-6736(18)32225-6.
• Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115mmHg, 1990-2015. JAMA - Journal of the American Medical Association. 2017; 317(2): 165-182. doi:10.1001/jama.2016.19043.
• Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of nonoptimal blood pressure. J Hypertens. 2009; 27(7): 1472-1477. DOI: 10.1097/HJH.0b013e32832a9ba3.
• Beştemir A, Aydın H. 300 million patient examinations per year; Evaluation of emergency and polyclinic services of 2nd and 3rd stage public health facilities in Turkey. Sakarya Med J. 2022; 12(3): 496-502. DOI: 10.31832/smj.1128439.
• Beaney T, Schutte AE, Stergiou GS, et al. May measurement month 2019: The global blood pressure screening campaign of the international society of hypertension. Hypertension. 2020; 76(2): 333-341. DOI: 10.1161/hypertensionaha.120.14874.
• World Health Organization. National household health survey in Turkey: prevalence of noncommunicable disease risk factors 2017. https://apps.who.int/iris/handle/10665/342200. Publication date: 2017.
• Silva RP, Lima JW, Medeiros RP, et al. Blood pressure measurement in different outpatient clinics. Kidney Blood Press Res. 2010; 33(3): 235-239. DOI: 10.1159/000317101.
• Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study Lancet. 2017; 390(10112):2549-2558. DOI: 10.1016/S0140-6736(17)32478-9.